ChartMill assigns a Buy % Consensus number of 85% to CAMP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-09-16 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-09-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-27 | Wedbush | Initiate | Outperform |
| 2024-11-05 | Leerink Partners | Initiate | Outperform |
| 2024-11-05 | William Blair | Initiate | Outperform |
| 2024-11-05 | JP Morgan | Initiate | Overweight |
| 2024-11-05 | Piper Sandler | Initiate | Overweight |
| 2024-01-11 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-10-09 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-10-06 | Roth MKM | Maintains | Buy -> Buy |
| 2023-10-06 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2023-08-29 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-07-13 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-07-11 | Craig-Hallum | Maintains | Buy -> Buy |
| 2023-06-26 | Jefferies | Downgrade | Buy -> Hold |
| 2023-05-01 | Goldman Sachs | Maintains | Sell |
| 2023-04-28 | Craig-Hallum | Maintains | Buy |
| 2023-04-18 | Goldman Sachs | Maintains | Sell |
| 2022-10-14 | Goldman Sachs | Maintains | Sell |
| 2022-08-16 | Craig-Hallum | Upgrade | Hold -> Buy |
| 2021-12-22 | Canaccord Genuity | Maintains | Buy |
| 2021-12-22 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2021-06-25 | Roth Capital | Maintains | Buy |
| 2021-04-23 | Canaccord Genuity | Maintains | Buy |
| 2021-03-18 | Canaccord Genuity | Maintains | Buy |
12 analysts have analysed CAMP and the average price target is 8.93 USD. This implies a price increase of 49.75% is expected in the next year compared to the current price of 5.96.
The consensus rating for CAMP4 THERAPEUTICS CORP (CAMP) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering CAMP4 THERAPEUTICS CORP (CAMP) is 12.